167 related articles for article (PubMed ID: 16023739)
1. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma.
Saylam G; Yücel OT; Sungur A; Onerci M
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):227-34. PubMed ID: 16023739
[TBL] [Abstract][Full Text] [Related]
2. Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas.
Brieger J; Wierzbicka M; Sokolov M; Roth Y; Szyfter W; Mann WJ
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):727-31. PubMed ID: 15210553
[TBL] [Abstract][Full Text] [Related]
3. Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study.
Zhang M; Sun X; Yu H; Hu L; Wang D
Acta Histochem; 2011 Oct; 113(6):626-30. PubMed ID: 20688360
[TBL] [Abstract][Full Text] [Related]
4. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis.
Liu Z; Wang J; Wang H; Wang D; Hu L; Liu Q; Sun X
Acta Otolaryngol; 2015 Jan; 135(1):51-7. PubMed ID: 25384380
[TBL] [Abstract][Full Text] [Related]
5. Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta.
Montag AG; Tretiakova M; Richardson M
Am J Clin Pathol; 2006 Jun; 125(6):832-7. PubMed ID: 16690481
[TBL] [Abstract][Full Text] [Related]
6. [Expression of PCNA, VEGF and bFGF in endothelial cells of juvenile nasopharyngeal angiofibroma].
Sun Y; Wu Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(23):1076-8. PubMed ID: 17285972
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma.
Dillard DG; Cohen C; Muller S; Del Gaudio J; Reichman O; Parrish B; Rackley D; Gal AA
Arch Otolaryngol Head Neck Surg; 2000 Jun; 126(6):723-5. PubMed ID: 10864108
[TBL] [Abstract][Full Text] [Related]
8. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA).
Ponti G; Losi L; Pellacani G; Rossi GB; Presutti L; Mattioli F; Villari D; Wannesson L; Alicandri Ciufelli M; Izzo P; De Rosa M; Marone P; Seidenari S
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):173-8. PubMed ID: 18227724
[TBL] [Abstract][Full Text] [Related]
9. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases.
Hwang HC; Mills SE; Patterson K; Gown AM
Mod Pathol; 1998 Nov; 11(11):1122-6. PubMed ID: 9831211
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.
Kansakar E; Chang YJ; Mehrabi M; Mittal V
Am Surg; 2009 Sep; 75(9):785-9; discussion 789. PubMed ID: 19774949
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in juvenile nasopharyngeal angiofibromas.
Coutinho-Camillo CM; Brentani MM; Nagai MA
Head Neck; 2008 Mar; 30(3):390-400. PubMed ID: 18228521
[TBL] [Abstract][Full Text] [Related]
12. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
13. [Significance of heparanase, bFGF and VEGF in angiogenesis for nasopharyngeal angiofibroma outspreading].
Wang J; Yi Z; Zhao D; Chen M; Li Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 25(21):970-3, 976. PubMed ID: 22260074
[TBL] [Abstract][Full Text] [Related]
14. The presence of tumor-infiltrating IL-17-producing cells in juvenile nasopharyngeal angiofibroma tumor microenvironment is a poor prognostic factor.
Sun X; Guo L; Wang H; Yu H; Wang J; Meng X; Liu Z; Liu J; Hu L; Li H; Wang D
Am J Otolaryngol; 2014; 35(5):582-8. PubMed ID: 25014998
[TBL] [Abstract][Full Text] [Related]
15. Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance.
Wang JJ; Sun XC; Hu L; Liu ZF; Yu HP; Li H; Wang SY; Wang DH
Head Neck; 2013 Dec; 35(12):1719-25. PubMed ID: 23471755
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C, GLUT-1, and syndecan-2 expression in juvenile nasopharyngeal angiofibroma: correlations to vessel density and tumor stage.
Renkonen S; Heikkilä P; Haglund C; Mäkitie AA; Hagström J
Head Neck; 2013 Jul; 35(7):1036-42. PubMed ID: 22791513
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Inducible Factor-1α (HIF-1α) Expression on Endothelial Cells in Juvenile Nasopharyngeal Angiofibroma: A Review of 70 cases and Tissue Microarray Analysis.
Song X; Yang C; Zhang H; Wang J; Sun X; Hu L; Liu Z; Wang D
Ann Otol Rhinol Laryngol; 2018 Jun; 127(6):357-366. PubMed ID: 29717655
[TBL] [Abstract][Full Text] [Related]
18. Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence.
Sidle DM; Maddalozzo J; Meier JD; Cornwell M; Stellmach V; Crawford SE
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):990-5. PubMed ID: 16301371
[TBL] [Abstract][Full Text] [Related]
19. Juvenile nasopharyngeal angiofibroma: analysis of 42 cases and important aspects of endoscopic approach.
Midilli R; Karci B; Akyildiz S
Int J Pediatr Otorhinolaryngol; 2009 Mar; 73(3):401-8. PubMed ID: 19124161
[TBL] [Abstract][Full Text] [Related]
20. Orbital cavernous haemangiomas: immunohistochemical study of proliferative capacity, vascular differentiation and hormonal receptor status.
Gupta A; Prabhakaran VC; Dodd T; Davis G; Selva D
Orbit; 2012 Dec; 31(6):386-9. PubMed ID: 23088382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
